Epidemiology of cutaneous melanoma: Descriptive data in France and Europe;Épidémiologie du mélanome cutané: Données descriptives en France et en Europe

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 12, 2005, Pages 975-982

  Grange, F ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORBIDITY; SKIN TUMOR; SOUTHERN EUROPE; WESTERN EUROPE; ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIOLOGY; INCIDENCE; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; ONSET AGE; PRESCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; EUROPE; FEMALE; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MELANOMA; MIDDLE AGED; SEX FACTORS; SKIN NEOPLASMS;

EID: 31844448481     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(05)79560-0     Document Type: Short Survey

References (35)

1. Behamou E, Laplanche A, Wartelle M, Faivre J, Cignoux M, Ménégoz F, et al. Incidence des cancers en France 1978-1982. Paris: Éditions Inserm, 1990.
2. Ménégoz F, Chérié-Challine L. Le cancer en France : incidence et mortalité. Paris: La documentation française, 1998.
3. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Ménégoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51:3-30.
4. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Ménégoz F, et al. Estimations nationales : tendances de l'incidence et de la mortalité par cancer en France entre 1978 et 2000. BEH 2003;41-42:190-3.
5. Cherié-Challine L, Halna JM, Remontet L. Situation épidémiologique du mélanome cutané en France et impact en termes de prévention. BEH 2004;2:5-8.
6. Halna JM. Mélanome de la peau, in Remontet L, Buemi A, Veiten M, Jougla E, Esteve J. Évolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000, Institut de Veille Sanitaire, Actis, Paris, 2002:93-98.
7. www.invs.sante.fr
8. www.encr.com.fr
9. www.depdb.iarc.fr/globocan2002.htm
10. www.arer68.org
11. Brisson C, Reynaud-Hautin C, Bure E, Chatal M, Hadet-Riegert M, Rafstedt P, et al. Étude épidémiologique prospective sur 115 nouveaux mélanomes cutanés en Vendée en 1997. Nouv Dermatol 1999;18:225-6.
12. Bernard P, Derancourt C, Arnoult-Coudoux E, Picot R, Delvincourt C, Association des Dermatologues de Champagne-Ardenne. Étude prospective de l'incidence des cancers cutanés dépistés en pratique dermatologique dans la région Champagne-Ardenne. Ann Dermatol Venereol 2001;28:883-7.
13. Gerbaut L, Lejeune ML, Abou-Samra T, Doz M, Mathey MF, D'Incan M, et al. Epidemiological survey of melanoma in the Auvergne region (France): is there an increased incidence in Auvergne? Eur J Epidemiol 2003;18:331-5.
14. Baccard M, Havard S, Souques M, Groupe mélanome de PETRI. Étude prospective de l'incidence du mélanome dans la région Ile-de-France en 1994. BEH 1996;131-2.
15. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1977: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003;107:119-26.
16. Groslaude P, Hedelin G, Macé-Lesech J, Ménégoz F, Carli PM, Launoy G, et al. Survie des patients cancéreux en France et en Europe : résultats de l'étude Eurocare pour la période 1990-1994. BEH 2003;41-42:202-4.
17. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-85.
18. McKie R, Hunter JA, Aitchison TC, Hole D, McLaren K, Rankin R, et al. Cutaneous malignant melanoma, Scotland, 1979-1989. Lancet 1992;339:971-5.
19. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001;14:280-90.
20. Van der Rhee HJ, Van der Spek-Keijser LM, Van Westering R, Coebergh JW. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980-95. Br J Dermatol 1999;140:463-7.
21. Vinceti M, Bergomi M, Borciani N, Serra L, Vivoli G. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res 1999;9:97-103.
22. De Vries E, Boniol M, Doré JF, Coeberg JW, Eurocare working group. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004;40:1045-52.
23. La Vecchia C, Lucchini F, Negri F, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999;81:62-6.
24. Stang A, Jöckel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 2003;13:436-42.
25. MacLennan R, Green AC, Mc Leod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992;84:1427-32.
26. Dennis LK. Analysis of the melanoma epidemic, both apparent and real. Arch Dermatol 1999;135:275-80.
27. Marks R. The changing incidence and mortality of melanoma in Australia. Recent results. Cancer Res 2002;160:113-21.
28. Beddingfield FC. The melanoma epidemic: Res Ipsa Loquitur. The Oncologist 2003;8:459-65.
29. Florez A, Cruces M. Melanoma epidemic: true or false? Int J Dermatol 2004;43:405-7.
30. Van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnosis criteria as a cause of increase of malignant melanoma over time is unlikely. Int J Cancer 1991;47:483-90.
31. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997;73:198-203.
32. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi and skin cancer. J Invest Dermatol 2003;120:1087-13.
33. Veierod MB, Weiderpass E, Thorn M, Hansson J, Lund E, Armstrong B, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous melanoma in women. J Nat Cancer Inst 2003;95:1530-8.
34. Lipsker D, Hedelin G, Held E, Grosshans E, Cribier B. Striking increase of thin melanoma contrasts with stable incidence of thick melanomas. Arch Dermatol 1999;135:1451-6.
35. Kolmel KF, Kulle B, Lippold A, Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer 2002;38:1388-94.